SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-049400
Filing Date
2024-04-19
Accepted
2024-04-19 15:31:07
Documents
15
Period of Report
2024-04-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2412196d4_8k.htm   iXBRL 8-K 30239
2 EXHIBIT 5.1 tm2412196d4_ex5-1.htm EX-5.1 9741
6 GRAPHIC tm2412196d4_ex5-1img001.jpg GRAPHIC 2100
  Complete submission text file 0001104659-24-049400.txt   221690

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bpth-20240419.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpth-20240419_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpth-20240419_pre.xml EX-101.PRE 22373
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2412196d4_8k_htm.xml XML 3700
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 24857458
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)